2.50Open2.50Pre Close0 Volume4 Open Interest17.50Strike Price0.00Turnover193.56%IV18.57%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry2.50Extrinsic Value100Contract SizeAmericanOptions Type-0.3687Delta0.0493Gamma7.37Leverage Ratio-0.0862Theta-0.0039Rho-2.72Eff Leverage0.0149Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet